Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
Christopher Yaen
Overview
Structured Data
Issues
Contributors
Activity
All edits
Edits on 14 Dec, 2021
"Remove inverse infobox"
Golden AI
edited on 14 Dec, 2021
Edits made to:
Infobox
(
-29
properties)
Infobox
Patent primary examiner of
US Patent 7115265 Four genetic tumor markers specific for human glioblastoma
US Patent 7115722 Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
US Patent 7135177 Immunoliposomes that optimize internalization into target cells
US Patent 7176289 Modulation of endothelial cell surface receptor activity in the regulation of angiogenesis
US Patent 7264820 Cancer immunotherapy using autologous tumor cells combined with cells expressing a membrane cytokline
US Patent 7303911 Prostate cell lines
US Patent 7317077 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
US Patent 7323168 Immunotherapy for chronic myelocytic leukemia
US Patent 7326529 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
US Patent 7338658 Recombinant anti-CD4 antibodies for human therapy
US Patent 7354713 Method of using estrogen-related receptor gamma (ERRγ) status to determine prognosis and treatment strategy for breast cancer, method of using ERRγ as a therapeutic target for treating breast cancer, method of using ERRγ to diagnose breast cancer, and method of using ERRγ to identify individuals predisposed to breast cancer
US Patent 7358351 Endothelial cell expression patterns
US Patent 7361332 Treating tumors using implants comprising combinations of allogeneic cells
US Patent 7361730 Surface localized colligin/Hsp47 in carcinoma cells
US Patent 7364726 Pharmaceutical composition for cancer treatment containing cells that express a membrane cytokine
US Patent 7375192 Antibodies that specifically bind to chemokine beta-4
US Patent 7381799 Compositions and methods for inhibiting angiogenesis
US Patent 7388088 High affinity human antibodies to tumor antigens
US Patent 7390871 Tumor antigen based on products of the tumor suppressor gene WT1
US Patent 7390882 Compositions and methods for the diagnosis and treatment of tumor
US Patent 7396681 Application of Hsp70 proteins
US Patent 7396920 Tumour suppressor and uses thereof
US Patent 7402306 Cancer immunotherapy with semi-allogeneic cells
US Patent 7402660 Endothelial cell expression patterns
US Patent 7405060 Gene amplification methods
US Patent 7410756 Methods of modulating angiogenesis
US Patent 7420032 Dominant B cell epitopes and methods of making and using thereof
US Patent 7449557 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
US Patent 7521540 CYR61 compositions and methods
Edits on 2 Dec, 2021
Golden AI
edited on 2 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7521540 CYR61 compositions and methods
Edits on 1 Dec, 2021
Golden AI
edited on 1 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7449557 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
Golden AI
edited on 1 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7420032 Dominant B cell epitopes and methods of making and using thereof
Golden AI
edited on 1 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7410756 Methods of modulating angiogenesis
Golden AI
edited on 30 Nov, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7405060 Gene amplification methods
Edits on 30 Nov, 2021
Golden AI
edited on 30 Nov, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7402660 Endothelial cell expression patterns
Golden AI
edited on 30 Nov, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7402306 Cancer immunotherapy with semi-allogeneic cells
Golden AI
edited on 30 Nov, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7396920 Tumour suppressor and uses thereof
Golden AI
edited on 30 Nov, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7396681 Application of Hsp70 proteins
Golden AI
edited on 30 Nov, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7390882 Compositions and methods for the diagnosis and treatment of tumor
Golden AI
edited on 30 Nov, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7390871 Tumor antigen based on products of the tumor suppressor gene WT1
Golden AI
edited on 30 Nov, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7388088 High affinity human antibodies to tumor antigens
Golden AI
edited on 30 Nov, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7381799 Compositions and methods for inhibiting angiogenesis
Golden AI
edited on 29 Nov, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7375192 Antibodies that specifically bind to chemokine beta-4
Edits on 26 Nov, 2021
Golden AI
edited on 26 Nov, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7364726 Pharmaceutical composition for cancer treatment containing cells that express a membrane cytokine
Edits on 25 Nov, 2021
Golden AI
edited on 25 Nov, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7361730 Surface localized colligin/Hsp47 in carcinoma cells
Golden AI
edited on 25 Nov, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7361332 Treating tumors using implants comprising combinations of allogeneic cells
Golden AI
edited on 25 Nov, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7358351 Endothelial cell expression patterns
Golden AI
edited on 25 Nov, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7354713 Method of using estrogen-related receptor gamma (ERRγ) status to determine prognosis and treatment strategy for breast cancer, method of using ERRγ as a therapeutic target for treating breast cancer, method of using ERRγ to diagnose breast cancer, and method of using ERRγ to identify individuals predisposed to breast cancer
Load more
Find more people like Christopher Yaen
Use the Golden Query Tool to discover related individuals, professionals, or experts with similar interests, expertise, or connections in the Knowledge Graph.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE